Clinical and cost-effectiveness of ACE inhibitors in patients with arterial hypertension and coronary heart disease

Clinical and cost-effectiveness of ACE inhibitors in patients with arterial hypertension and coronary heart disease

Aim. To compare clinical and cost-effectiveness of ACE inhibitors in patients with arterial hypertension (AH) and coronary heart disease (CHD), aiming to guide the appropriate medication selection process.Material and methods. The study included 60 patients, receiving standard combined pharmaceutica...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. Yu. Korennova, A. V. Petrenko, M. A. Petrenko, E. V. Kurt-Kovalenko, E. A. Turusheva, T. A. Natsarenus, S. V. Alekseeva, L. G. Mashinskaya, M. I. Shupina, E. A. Osipova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2008-08-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	arterial hypertension clinical and cost-effectiveness of the treatment
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1551
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CLINICAL AND COST EFFECTIVENESS OF PREVENTIVE COUNSELING OF YOUNG PATIENTS WITH ARTERIAL HYPERTENSION IN PRIMARY HEALTH CARE
by: M. I. Shupina, et al.
Published: (2015-09-01)

ACE inhibitor zofenopril effectiveness in arterial hypertension treatment
by: D. A. Napalkov, et al.
Published: (2008-12-01)

ACE inhibitor trandolapril effectiveness in arterial hypertension
by: K. I. Tebloev, et al.
Published: (2008-04-01)

Zofenopril (Zocardis) - cardioprotective ace inhibitor; clinical pharmacology and arterial hypertension treament experience
by: D. V. Preobrazhensky, et al.
Published: (2006-02-01)

EVIDENCE-BASED CHOICE OF ACE INHIBITORS
by: G. E. Gendlin, et al.
Published: (2012-08-01)

Clinical efficacy and vasoprotection of ACE inhibitors and beta3blockers in patients with arterial hypertension
by: Zh. N. Namsaraev, et al.
Published: (2004-02-01)

ACE inhibitors and myocardial remodeling in patients with arterial hypertension and atrial fibrillation
by: O. N. Miller, et al.
Published: (2007-10-01)

ACE INHIBITORS IN ARTERIAL HYPERTENSION TREATMENT: FOCUS ON LISINOPRIL
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

MECHANISMS OF COMBINED ACTION OF ACE INHIBITORS AND CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION
by: E. I. Astashkin, et al.
Published: (2013-06-01)

SIGNIFICANCE OF BASELINE ACE ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME WHEN ADMINISTRATION OF ACE INHIBITORS AND IMIDAZOLINE AGONISTS IS CONSIDERED
by: T. V. Aparina, et al.
Published: (2001-04-01)

Effectiveness of ACE inhibitor ramipril and its combination with hydrochlorothiazide in patients with arterial hypertension and overweight: CHARISMA Study
by: I. P. Kolos, et al.
Published: (2008-04-01)

Ace inhibitor spirapril effects on structural and functional vascular wall parameters in metabolic syndrome and essential arterial hypertension
by: V. E. Oleynikov, et al.
Published: (2006-04-01)

ACE inhibitors in arterial hypertension management: zofenopril – class-specific effects and extra benefits
by: V. S. Zadionchenko, et al.
Published: (2007-04-01)

Comparative efficacy of ace inhibitor spirapril in hypertensive patients from various age groups
by: L. A. Sokolova, et al.
Published: (2006-06-01)

Effectiveness and safety of the ACE inhibitor and diuretic combination in postmenopausal women with arterial hypertension
by: G. G. Semenkova, et al.
Published: (2011-06-01)

Combined therapy of arterial hypertension: focusing on a fixed-dose calcium antagonist/ACE inhibitor combination
by: D. V. Preobrazhensky, et al.
Published: (2008-08-01)

NEW EVALUATION METHOD FOR EFFICACY OF HYPOTENSIVE TREATMENT WITH ACE INHIBITORS
by: V. V. Shkarin, et al.
Published: (2003-06-01)

COMPARISON OF ACE INHIBITOR (FOSINOPRIL) AND Β-ADRENOBLOCKER (ATENOLOL) EFFECTS ON AUTONOMIC REGULATION OF THE HEART IN PATIENTS WITH ARTERIAL HYPERTENSION
by: A. R. Kiselyov, et al.
Published: (2016-01-01)

The Effect of ACE Inhibitors/ARBs Withdrawal on the Risk of Postoperative Complications in Abdominal Surgery
by: N. V. Trembach, et al.
Published: (2023-10-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
by: E. M. Khurs, et al.
Published: (2016-01-01)

ADVANTAGES AND NOVELTY OF CLINICAL APPLICATION OF THE TRIPLE COMBINATION FOR ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA: ACE INHIBITOR PERINDOPRIL WITH ROSUVASTATIN AND INDAPAMIDE
by: M. L. Maksimov, et al.
Published: (2017-08-01)

New potential of ACE inhibitors in clinical practice
by: D. V. Nebieridze, et al.
Published: (2010-10-01)

ACE inhibitor effects of brachial artery structure and function in patients with arterial hypertension
by: L. V. Melnikova
Published: (2012-04-01)

Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
by: V. I. Makolkin
Published: (2008-12-01)

Spirapril – a modern ACE inhibitor
by: V. M. Gorbunov
Published: (2005-06-01)

Adverse effects of ACE inhibitors and cardiovascular treatment tactics
by: V. A. Orlov, et al.
Published: (2005-06-01)

Comparative effectiveness of ACE inhibitors spirapril, fosinopril, and enalapril in complex therapy of patients with coronary heart disease, chronic obstructive pulmonary disease, and arterial hypertension
by: M. A. Popova, et al.
Published: (2006-06-01)

ACE inhibitors in arterial hypertension treatment among various clinical groups
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk
by: O. Yu. Korennova, et al.
Published: (2019-01-01)

Angiotensin II receptor antagonist and ACE inhibitor effectiveness in cognitive function correction among elderly patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2007-06-01)

Pleiotropic ACE inhibitor effects: any benefits for sulfhydryl agents?
by: D. V. Preobrazhensky, et al.
Published: (2008-02-01)

COMPARATIVE ASSESSMENT OF EFFECT OF COMBINED DRUGS OF ACE INHIBITOR AND DIURETIC (“NOLIPREL FORTE” AND “CAPOZIDE”) ON CARDIOVASCULAR REMODELING IN HYPERTENSIVE PATIENTS
by: T. D. Kaplanov, et al.
Published: (2015-12-01)

ACE inhibitor in complex therapy of functional class II-III chronic heart failure in patients with chronic obstructive pulmonary disease
by: A. G. Evdokimova, et al.
Published: (2005-12-01)

Arterial hypertension treatment with a calcium channel blocker and an ACE inhibitor. Benefits of combination therapy
by: E. O. Taratukhin
Published: (2013-06-01)

ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION
by: M. P. Metrova, et al.
Published: (2016-01-01)

PREVENTION OF ANTRACYCLIN ANTIBIOTIC DOXORUBICIN СARDIOTOXICITY: A ROLE OF ACE-INHIBITOR PERINDOPRIL
by: E. V. Pravdivtseva, et al.
Published: (2014-07-01)

ACE inhibitors in patients with heart failure
by: O. P. Shevchenko, et al.
Published: (2008-10-01)

Clinical and pharmaco-economic assessment of ACE inhibitors perindopril and enalapril in coronary heart disease patients after coronary artery bypass graft surgery
by: Yu. M. Lopatin, et al.
Published: (2009-06-01)

Cardiovascular disease and ACE inhibitors: focusing on enalapril
by: G. A. Baryshnikova
Published: (2007-12-01)

ACE inhibitors in the treatment of paroxysmal atrial fibrillation
by: B. A. Tatarsky
Published: (2005-06-01)